Johnson Pharmacare posts Rs 110.31 lakh Q1 loss; auditor flags emphasis of matter

Emphasis of matterNet loss reportedExceptional itemResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹0.47

prior close

₹0.46

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-0.1% vs market

Diversified Commercial Services peers, median of 72sector-0.7%+0.7% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.7 pts more than its Diversified Commercial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.2

10m

+2.2

15m

+2.2

30m

+2.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0+0.1-0.1-0.7+0.7

Next day

+0.0+0.2-0.2-1.2+1.2

+0.0+0.6-0.6-1.0+1.0

-2.1-0.0-2.1-1.5-0.6

+0.0+0.5-0.5-1.6+1.6

+0.0+0.8-0.8-1.4+1.4

+0.0+0.6-0.6-1.0+1.0

15d

+0.0+1.3-1.3-1.9+1.9

+0.0-1.4+1.4-3.6+3.6

-10.6-0.6-10.1-4.8-5.8

—————

UpDownMarket · Nifty Microcap 250Sector · Diversified Commercial Services peers, median of 72Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Johnson Pharmacare reported Q1 FY27 (June 2026) total income of Rs 158.10 lakh and a net loss of Rs 110.31 lakh. FY26 full year loss was Rs 5,573.39 lakh including Rs 1,427 lakh exceptional items. Statutory auditor VRSK and Associates issued a limited review report with an emphasis of matter and noted the results may not fully comply with Ind AS standards. The company continues to post persistent losses with an additional director signing the filing.

Likely market impact

Persistent losses, auditor emphasis of matter, and Ind AS compliance concerns are negative signals for shareholders.